Writing An Effective 483 Response 5th Annual FDA and the Changing Paradigm for HCT/P Regulation University of Rhode Island and Pharma Conference Las Vegas, NV, January 2009…

1. Stephanie Nishi Spencer Lee Andrew Walnum Gurmeet Marwaha Period 5, Biotechnology 2. The Scenario What can Biotex offer this scientist in order to avoid going out of business?…

1. Compliance with the FDAGuidances on Investigator Responsibilities and the Form 1572Presented byPaul Below, CCRA, CCRTP. Below Consulting, Inc. 2. About the Speaker•…

Slide 1FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events S. Percy Ivy, MD Associate Chief, Senior Investigator Investigational Drug Branch,…

1. 1Preparing for an FDAPre-Approval Inspection (PAI)Jorge TorresCMQ/OE, CQE, CQAJuly, 2007 2. 2Agendal Introductionl Understanding the PAI Experience:What to Expectl Inspection…

1. S C H E R I N G - P L O U G H C O R P O R AT I O N 2 0 0 1 A N N UA L R E P O RT 2. CONTENTS PROFILE S C H E R I N G - P L O U G H C O R P O R AT I O NCONTENTSPROFILE…

Slide 1 FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events S. Percy Ivy, MD Associate Chief, Senior Investigator Investigational Drug Branch,…

Slide 1 1 GOOD MANUFACTURING PRACTICES IN A QUALITY WORLD Gordon Harnack President, Oracle Consulting Group Tucson, AZ www.fdamaze.com Slide 2 2 The Discussion Plan Definitions…